{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:46:19Z","timestamp":1782384379823,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00044-026-03563-0","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:21:50Z","timestamp":1777368110000},"page":"1088-1104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synthesis and structure\u2013activity relationship studies of 1,2,4-triazole\u2013benzoxazepine hybrids as \u03b1-glucosidase inhibitors: molecular docking and biological evaluation"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1401-9282","authenticated-orcid":false,"given":"Muhammad","family":"Ashram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almeqdad Y.","family":"Habashneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza I.","family":"Al-Hrerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Al-Sha\u2019er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas F.","family":"Awwadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam","family":"Ashram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"3563_CR1","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.mcna.2004.04.013","volume":"355","author":"RA DeFronzo","year":"2004","unstructured":"DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;355:787 https:\/\/doi.org\/10.1016\/j.mcna.2004.04.013.","journal-title":"Med Clin North Am"},{"key":"3563_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5897\/JPAP2013.0001","volume":"4","author":"JC Ozougwu","year":"2013","unstructured":"Ozougwu JC, Obimba KC, Belonwu CD, Unakalamba CB. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol. 2013;4:46 https:\/\/doi.org\/10.5897\/JPAP2013.0001.","journal-title":"J Physiol Pathophysiol"},{"key":"3563_CR3","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.3390\/molecules27103091","volume":"27","author":"L Durmaz","year":"2022","unstructured":"Durmaz L, Erturk A, Aky\u00fczet M, Kose LP, Uc EM, Bingol Z, et al. Screening of carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase, and \u03b1-glycosidase enzyme inhibition effects and antioxidant activity of coumestrol. Molecules. 2022;27:3091 https:\/\/doi.org\/10.3390\/molecules27103091.","journal-title":"Molecules"},{"key":"3563_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4239\/wjd.v1.i3.68","volume":"1","author":"V Saini","year":"2010","unstructured":"Saini V. Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J Diabetes. 2010;1:68 https:\/\/doi.org\/10.4239\/wjd.v1.i3.68.","journal-title":"World J Diabetes"},{"key":"3563_CR5","doi-asserted-by":"publisher","first-page":"102037","DOI":"10.1016\/j.bbrep.2025.102037","volume":"42","author":"B Gieroba","year":"2025","unstructured":"Gieroba B, Kryska A, Sroka-Bartnicka A. Type 2 diabetes mellitus \u2013 conventional therapies and future perspectives in innovative treatment. Biochem Biophys Rep. 2025;42:102037 https:\/\/doi.org\/10.1016\/j.bbrep.2025.102037.","journal-title":"Biochem Biophys Rep"},{"key":"3563_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cct.2018.09.003","volume":"74","author":"L Faroqi","year":"2018","unstructured":"Faroqi L, Wong M, Bonde S, Wong CW, Walai K, West W, et al. Evaluating the clinical implementation of structured exercise: A randomized controlled trial among non-insulin-dependent type II diabetics. Contemp Clin Trials. 2018;74:25 https:\/\/doi.org\/10.1016\/j.cct.2018.09.003.","journal-title":"Contemp Clin Trials"},{"key":"3563_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bioorg.2017.05.007","volume":"73","author":"MJ Naim","year":"2017","unstructured":"Naim MJ, Alam MJ, Nawaz F, Naidu VGM, Aaghaz S, Sahu M, et al. Synthesis, molecular docking, and anti-diabetic evaluation of 2,4-thiazolidinedione-based amide derivatives. Bioorg Chem. 2017;73:24 https:\/\/doi.org\/10.1016\/j.bioorg.2017.05.007.","journal-title":"Bioorg Chem"},{"key":"3563_CR8","doi-asserted-by":"crossref","unstructured":"American diabetes association diagnosis and classification of diabetes mellitus, Diabetes Care 2006;29:S43.","DOI":"10.2337\/diacare.29.s1.06.s43"},{"key":"3563_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2522\/ptj.20080020","volume":"88","author":"AD Deshpande","year":"2008","unstructured":"Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther. 2008;88:1254 https:\/\/doi.org\/10.2522\/ptj.20080020.","journal-title":"Phys Ther"},{"key":"3563_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12933-021-01321-7","volume":"20","author":"X Zhao","year":"2021","unstructured":"Zhao X, Wang Y, Chen R, Li J, Zhou J, Liu C, et al. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study. Cardiovasc Diabetol. 2021;20:131 https:\/\/doi.org\/10.1186\/s12933-021-01321-7.","journal-title":"Cardiovasc Diabetol"},{"key":"3563_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fnagi.2020.00217","volume":"12","author":"Y Kong","year":"2020","unstructured":"Kong Y, Wang F, Wang J, Liu C, Zhou Y, Xu Z, et al. Pathological mechanisms linking diabetes mellitus and Alzheimer\u2019s disease: the receptor for advanced glycation end products (RAGE). Front Aging Neurosci. 2020;12:217.","journal-title":"Front Aging Neurosci"},{"key":"3563_CR12","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1113\/jphysiol.2014.272328","volume":"592","author":"C Mora-Fern\u00e1ndez","year":"2014","unstructured":"Mora-Fern\u00e1ndez C, Dom\u00ednguez-Pimentel V, de Fuentes MM, G\u00f3rriz JL, Mart\u00ednez-Castelao A, Navarro-Gonz\u00e1lez JF. Diabetic kidney disease: from physiology to therapeutics. J Physiol. 2014;592:3997 https:\/\/doi.org\/10.1113\/jphysiol.2014.272328.","journal-title":"J Physiol"},{"key":"3563_CR13","doi-asserted-by":"publisher","first-page":"112431","DOI":"10.1016\/j.diabres.2025.112431","volume":"228","author":"M Anson","year":"2025","unstructured":"Anson M, Henney AE, Edwards H, Ibarburu GH, Mordi I, Jaffar S, et al. The rapidly increasing incidence of type 2 diabetes and macrovascular and microvascular complications disproportionately affects younger age groups: A decade of evidence from an international federated database. Diabetes Res Clin Pract. 2025;228:112431 https:\/\/doi.org\/10.1016\/j.diabres.2025.112431.","journal-title":"Diabetes Res Clin Pract"},{"key":"3563_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.thromres.2011.11.052","volume":"129","author":"N Vazzana","year":"2012","unstructured":"Vazzana N, Ranalli P, Cuccurullo C, Dav\u00ec G. Diabetes mellitus and thrombosis. Thromb Res. 2012;129:371 https:\/\/doi.org\/10.1016\/j.thromres.2011.11.052.","journal-title":"Thromb Res"},{"key":"3563_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-025-02401-w","volume":"11","author":"L Zhao","year":"2026","unstructured":"Zhao L, Yuan J, Yang Q, Ma J, Yang F, Zou Y, et al. Diabetes and its complications: molecular mechanisms, prevention and treatment. Signal Transduct Target Ther. 2026;11:22 https:\/\/doi.org\/10.1038\/s41392-025-02401-w.","journal-title":"Signal Transduct Target Ther"},{"key":"3563_CR16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/cmdc.201700216","volume":"12","author":"Z Liu","year":"2017","unstructured":"Liu Z, Ma S. Recent advances in synthetic \u03b1-glucosidase inhibitors. \u200fChem Med Chem. 2017;12:819 https:\/\/doi.org\/10.1002\/cmdc.201700216.","journal-title":"\u200fChem Med Chem"},{"key":"3563_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/1440-1681.12332","volume":"42","author":"ZX He","year":"2015","unstructured":"He ZX, Zhou ZW, Yang Y, Yang T, Pan SY, Qiu JX, et al. Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus. Clin Exp Pharmacol Physiol. 2015;42:125 https:\/\/doi.org\/10.1111\/1440-1681.12332.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3563_CR18","doi-asserted-by":"publisher","first-page":"111700","DOI":"10.1016\/j.ejmech.2019.111700","volume":"183","author":"Z Xu","year":"2019","unstructured":"Xu Z, Zhao S-J, Liu Y. 1,2,3-Triazole-containing hybrids as potential anticancer agents: current developments, action mechanisms and structure-activity relationships. Eur J Med Chem. 2019;183:111700 https:\/\/doi.org\/10.1016\/j.ejmech.2019.111700.","journal-title":"Eur J Med Chem"},{"key":"3563_CR19","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1016\/j.bmc.2007.08.029","volume":"15","author":"S Cai","year":"2007","unstructured":"Cai S, Li Q-S, Borchardt RT, Kuczera K, Schowen RL. The antiviral drug ribavirin is a selective inhibitor of S-adenosyl-l-homocysteine hydrolase from trypanosoma cruzi. Biorg Med Chem. 2007;15:7281 https:\/\/doi.org\/10.1016\/j.bmc.2007.08.029.","journal-title":"Biorg Med Chem"},{"issue":"24","key":"3563_CR20","doi-asserted-by":"publisher","first-page":"6036","DOI":"10.3390\/molecules29246036","volume":"29","author":"T Glomb","year":"2024","unstructured":"Glomb T, Minta J, Nowosadko M, Radzikowska J, \u015awi\u0105tek P. Search for new compounds with anti-inflammatory activity among 1,2,4-triazole derivatives. Molecules. 2024;29(24):6036 https:\/\/doi.org\/10.3390\/molecules29246036.","journal-title":"Molecules"},{"key":"3563_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2025.102628","volume":"152","author":"R Mehavi","year":"2025","unstructured":"Mehavi R, Vinayak W, Ashwini P, Jaini PK, Nuli MV, Dvrn B, et al. Integrative exploration of 2-phenylquinolin-4(1H)-one tethered 1,2,3-triazole derivatives: A comprehensive in vitro and in silico investigation towards novel anti-tubercular agents. Tuberculosis (Edinb). 2025;152:102628. https:\/\/doi.org\/10.1016\/j.tube.2025.102628.","journal-title":"Tuberculosis (Edinb)"},{"key":"3563_CR22","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1002\/cncr.10908","volume":"95","author":"AU Buzdar","year":"2002","unstructured":"Buzdar AU, Robertson JF, Eiermann W, Nabholtz JM. An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane. Cancer Interdiscip Int J Am Cancer Soc. 2002;95:2006 https:\/\/doi.org\/10.1002\/cncr.10908.","journal-title":"Cancer Interdiscip Int J Am Cancer Soc"},{"key":"3563_CR23","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1158\/1078-0432.CCR-07-5221","volume":"14","author":"J Geisler","year":"2008","unstructured":"Geisler J, Helle H, Ekse D, Duong NK, Evans DB, Nordb Y, et al. Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels. Clin Cancer Res. 2008;14:6330 https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-5221.","journal-title":"Clin Cancer Res"},{"key":"3563_CR24","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ejmech.2014.11.033","volume":"97","author":"\u015eG K\u00fc\u00e7\u00fckg\u00fczel","year":"2015","unstructured":"K\u00fc\u00e7\u00fckg\u00fczel \u015eG, \u00c7\u0131kla-S\u00fczg\u00fcn P. Recent advances bioactive 1,2,4-triazole-3-thiones. Eur J Med Chem. 2015;97:830 https:\/\/doi.org\/10.1016\/j.ejmech.2014.11.033.","journal-title":"Eur J Med Chem"},{"key":"3563_CR25","doi-asserted-by":"publisher","first-page":"104626","DOI":"10.1016\/j.arabjc.2023.104626","volume":"16","author":"HMA Asif","year":"2023","unstructured":"Asif HMA, Kamal S, ur-Rehman A, Bibi I. Synthesis characterization and evaluation of novel triazole based analogs as a acetylcholinesterase and \u03b1-glucosidase inhibitors. Arabian J Chem. 2023;16:104626 https:\/\/doi.org\/10.1016\/j.arabjc.2023.104626.","journal-title":"Arabian J Chem"},{"key":"3563_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.biopha.2017.07.139","volume":"94","author":"PA Channar","year":"2017","unstructured":"Channar PA, Saeed A, Larik FA, Rashid S. Design and synthesis of 2,6-di(substituted phenyl)thiazolo[3,2-b]-1,2,4-triazoles as \u03b1-glucosidase and \u03b1-amylase inhibitors, co-relative pharmacokinetics and 3D QSAR and risk analysis. Biomed Pharmacother. 2017;94:499 https:\/\/doi.org\/10.1016\/j.biopha.2017.07.139.","journal-title":"Biomed Pharmacother"},{"key":"3563_CR27","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1016\/j.jksus.2020.09.026","volume":"32","author":"RS Gani","year":"2020","unstructured":"Gani RS, Timanagouda K, Madhushree S, Shrinivas DJ. Synthesis of novel indole, 1,2,4-triazole derivatives as potential glucosidase inhibitors. J King Saud Univ. Sci. 2020;32:3388 https:\/\/doi.org\/10.1016\/j.jksus.2020.09.026.","journal-title":"J King Saud Univ. Sci"},{"key":"3563_CR28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1039\/D0NJ05298A","volume":"45","author":"R Dahmani","year":"2021","unstructured":"Dahmani R, Manachou M, Belaidi S, Chtita S, Boughdiri S. Structural characterization and QSAR modeling of 1,2,4-triazole derivatives as \u03b1-glucosidase inhibitors. New J Chem. 2021;45:1253 https:\/\/doi.org\/10.1039\/D0NJ05298A.","journal-title":"New J Chem"},{"key":"3563_CR29","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1007\/s11030-023-10728-1","volume":"8","author":"A Sharma","year":"2024","unstructured":"Sharma A, Dubey R, Bhupal R, Patel P. An insight on medicinal attributes of 1,2,3- and 1,2,4-triazole derivatives as alpha-amylase and alpha-glucosidase inhibitors. Mol Diver. 2024;8:3605 https:\/\/doi.org\/10.1007\/s11030-023-10728-1.","journal-title":"Mol Diver"},{"key":"3563_CR30","doi-asserted-by":"publisher","first-page":"22508","DOI":"10.1021\/acsomega.3c00702","volume":"8","author":"I Khan","year":"2023","unstructured":"Khan I, Rehman W, Rahim F, Hussain R, Khan S, Rasheed L, et al. Synthesis and in vitro \u03b1-amylase and \u03b1-glucosidase dual inhibitory activities of 1,2,4-triazole-bearing bis-hydrazone derivatives and their molecular docking study. ACS Omega. 2023;8:22508 https:\/\/doi.org\/10.1021\/acsomega.3c00702.","journal-title":"ACS Omega"},{"key":"3563_CR31","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.2174\/0115701808350303241230081711","volume":"21","author":"N Chaturvedi","year":"2024","unstructured":"Chaturvedi N, Bhattacharya S, Asati V, Chtita S, Kaya S, Almehizia AA, et al. Screening of novel 1,2,4-triazine clubbed 1,2,3-triazole derivatives as \u03b1-glucosidase inhibitors: in silico study. Lett Drug Des Discov. 2024;21:4894 https:\/\/doi.org\/10.2174\/0115701808350303241230081711.","journal-title":"Lett Drug Des Discov"},{"key":"3563_CR32","doi-asserted-by":"publisher","first-page":"115467","DOI":"10.1016\/j.bmc.2020.115467","volume":"28","author":"EO Yeye","year":"2020","unstructured":"Yeye EO, Kanwal, Khan KM, Chigurupati S, Wadood A, Ur Rehman A, et al. Syntheses, in vitro \u03b1-amylase and \u03b1-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies. Bioorg Med Chem. 2020;28:115467 https:\/\/doi.org\/10.1016\/j.bmc.2020.115467.","journal-title":"Bioorg Med Chem"},{"key":"3563_CR33","doi-asserted-by":"publisher","first-page":"138889","DOI":"10.1016\/j.molstruc.2024.138889","volume":"1315","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Yu X, Li J, Liang B, Sun J, Min X, et al. Design, synthesis and biological evaluation of novel betulinic acid derivatives containing 1,2,4-triazole-derived schiff bases as \u03b1-glucosidase inhibitors. J Mol Struct. 2024;1315:138889 https:\/\/doi.org\/10.1016\/j.molstruc.2024.138889.","journal-title":"J Mol Struct"},{"key":"3563_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1515\/znc-2024-0073","volume":"12","author":"SA Abbasi","year":"2024","unstructured":"Abbasi SA, Rahim F, Hussain R, Rehman W, Khan S, Taha M, et al. Synthesis of modified Schiff base appended 1,2,4-triazole hybrids scaffolds: elucidating the in vitro and in silico \u03b1-amylase and \u03b1-glucosidase inhibitors potential. Z Naturforsch C. 2024;12:119 https:\/\/doi.org\/10.1515\/znc-2024-0073.","journal-title":"Z Naturforsch C"},{"key":"3563_CR35","doi-asserted-by":"publisher","first-page":"345","DOI":"10.18185\/erzifbed.1216717","volume":"16","author":"F\u00d6Z Tuncay","year":"2023","unstructured":"Tuncay F\u00d6Z, \u00c7akmak \u00dc. Investigation of 1, 2, 4-triazole derivatives as potantial anti-diabetic agents: In vitro enzyme inhibition and in silico pharmacokinetic studies. Erzincan Univ J Sci Technol. 2023;16:345 https:\/\/doi.org\/10.18185\/erzifbed.1216717.","journal-title":"Erzincan Univ J Sci Technol"},{"key":"3563_CR36","doi-asserted-by":"publisher","first-page":"115920","DOI":"10.1016\/j.ejmech.2023.115920","volume":"262","author":"Q Feng","year":"2023","unstructured":"Feng Q, Zhang J, Luo S, Huang Y, Peng Z, Wang G. Synthesis, biological evaluation and action mechanism of 7H-[1,2,4] triazolo [3,4-b] [1,3,4] thiadiazine-phenylhydrazone derivatives as \u03b1-glucosidase inhibitors. Eur J Med Chem. 2023;262:115920 https:\/\/doi.org\/10.1016\/j.ejmech.2023.115920.","journal-title":"Eur J Med Chem"},{"key":"3563_CR37","doi-asserted-by":"publisher","first-page":"995820","DOI":"10.3389\/fchem.2022.995820","volume":"10","author":"Y Khan","year":"2022","unstructured":"Khan Y, Iqbal S, Shah M, Maalik A, Hussain R, Khan S, et al. New quinoline-based triazole hybrid analogs as effective inhibitors of \u03b1-amylase and \u03b1-glucosidase: preparation, in vitro evaluation, and molecular docking along with in silico studies. Front Chem. 2022;10:995820 https:\/\/doi.org\/10.3389\/fchem.2022.995820.","journal-title":"Front Chem"},{"key":"3563_CR38","doi-asserted-by":"publisher","first-page":"32360","DOI":"10.1021\/acsomega.2c03779","volume":"7","author":"HMA Asif","year":"2022","unstructured":"Asif HMA, Kamal S, Rehman A, Rasool S, Akash MSH. Synthesis, characterization, and enzyme inhibition properties of 1, 2, 4-triazole bearing azinane analogues. ACS Omega. 2022;7:32360 https:\/\/doi.org\/10.1021\/acsomega.2c03779.","journal-title":"ACS Omega"},{"key":"3563_CR39","doi-asserted-by":"publisher","first-page":"17024","DOI":"10.1021\/acs.joc.3c01929","volume":"88","author":"M Nigr\u00edni","year":"2023","unstructured":"Nigr\u00edni M, Bhosale VA, C\u00edsa\u0159ov\u00e1 I, Vesel\u00fd J. Enantioenriched 1,4-benzoxazepines via chiral br\u00f8nsted acid catalyzed enantioselective desymmetrization of 3-substituted oxetanes. J Org Chem. 2023;88:17024 https:\/\/doi.org\/10.1021\/acs.joc.3c01929.","journal-title":"J Org Chem"},{"issue":"5","key":"3563_CR40","doi-asserted-by":"publisher","first-page":"e202200617","DOI":"10.1002\/cmdc.202200617","volume":"18","author":"I Chatterjee","year":"2023","unstructured":"Chatterjee I, Ali K, Panda G. A synthetic overview of benzoxazines and benzoxazepines as anticancer agents. Chem. Med. Chem. 2023;18(5):e202200617 https:\/\/doi.org\/10.1002\/cmdc.202200617.","journal-title":"Chem. Med. Chem."},{"key":"3563_CR41","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1007\/s00044-020-02606-4","volume":"29","author":"P Thiyagamurthy","year":"2020","unstructured":"Thiyagamurthy P, Teja C, Naresh K, Gomathi K, Rahman F, Khan N. Design, synthesis and in silico evaluation of benzoxazepino (7, 6-b) quinolines as potential antidiabetic agents. Med Chem Res. 2020;29:1882 https:\/\/doi.org\/10.1007\/s00044-020-02606-4.","journal-title":"Med Chem Res"},{"key":"3563_CR42","doi-asserted-by":"publisher","first-page":"30215","DOI":"10.1021\/acsomega.2c03328","volume":"7","author":"R Mehmood","year":"2022","unstructured":"Mehmood R, Mughal EU, Elkaeed EB, Obaid RJ, Nazir Y, Al-Ghulikah HA, et al. Synthesis of novel 2,3-dihydro-1,5-benzothiazepines as \u03b1-glucosidase inhibitors: In vitro, in vivo, kinetic, SAR, molecular docking, and QSAR studies. ACS Omega. 2022;7:30215 https:\/\/doi.org\/10.1021\/acsomega.2c03328.","journal-title":"ACS Omega"},{"key":"3563_CR43","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1016\/j.bmcl.2016.04.018","volume":"26","author":"JE Wilson","year":"2016","unstructured":"Wilson JE, Kurukulasuriya R, Sinz C, Lombardo M, Bender K, Parker D, et al. Discovery and development of benzo-[1,2,4]-triazolo-[1,4]-oxazepine. Bio Med Chem Lett. 2016;26:2947 https:\/\/doi.org\/10.1016\/j.bmcl.2016.04.018.","journal-title":"Bio Med Chem Lett"},{"key":"3563_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00044-022-03001-x","volume":"32","author":"M Ashram","year":"2023","unstructured":"Ashram M, Habashneh AY, Bardaweel S, Taha MO. A click synthesis, molecular docking and biological evaluation of 1, 2, 3-triazoles-benzoxazepine hybrid as potential anticancer agents. Med Chem Res. 2023;32:271 https:\/\/doi.org\/10.1007\/s00044-022-03001-x.","journal-title":"Med Chem Res"},{"key":"3563_CR45","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.bmcl.2015.12.033","volume":"26","author":"F Jabeen","year":"2016","unstructured":"Jabeen F, Shehzadi SA, Fatmi MQ, Shaheen S, Iqbal L, Afza N, et al. Synthesis, in vitro and computational studies of 1,4-disubstituted 1,2,3-triazoles as potential \u03b1-glucosidase inhibitors. Bioorg Med Chem Lett. 2016;26:1029 https:\/\/doi.org\/10.1016\/j.bmcl.2015.12.033.","journal-title":"Bioorg Med Chem Lett"},{"key":"3563_CR46","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2174\/1573413715666181212150955","volume":"16","author":"M Balbaa","year":"2019","unstructured":"Balbaa M, Awad D, Elaal AA, Mahsoub S, Moharram M, Sadek O, et al. Action of thioglycosides of 1, 2, 4-triazoles and imidazoles on the oxidative stress and glycosidases in mice with molecular docking. \u200fLett in Drug Design & Discovery. 2019;16:696 https:\/\/doi.org\/10.2174\/1573413715666181212150955.","journal-title":"\u200fLett in Drug Design & Discovery"},{"key":"3563_CR47","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3390\/ph15081035","volume":"15","author":"N Cele","year":"2022","unstructured":"Cele N, Awolade P, Seboletswe P, Olofinsan K, Islam MdS, Singh P. \u03b1-Glucosidase and \u03b1-amylase inhibitory potentials of quinoline\u20131,3,4-oxadiazole conjugates bearing 1,2,3-triazole with antioxidant activity, kinetic studies, and computational validation. Pharma. 2022;15:1035 https:\/\/doi.org\/10.3390\/ph15081035.","journal-title":"Pharma"},{"key":"3563_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-31080-2","volume":"13","author":"SM Farid","year":"2023","unstructured":"Farid SM, Noori M, Montazer MN, Ghomi MK, Mollazadeh M, Dastyafteh N, et al. Synthesis and structure\u2013activity relationship studies of benzimidazole-thioquinoline derivatives as \u03b1-glucosidase inhibitors. Sci Rep. 2023;13:4392. https:\/\/doi.org\/10.1038\/s41598-023-31080-2.","journal-title":"Sci Rep"},{"key":"3563_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36046-y","volume":"13","author":"M Saeedi","year":"2023","unstructured":"Saeedi M, Hariri R, Iraji A, Ahmadi A, Mojtabavi S, Golshani S, et al. Novel N\u2032-substituted benzylidene benzohydrazides linked to 1,2,3-triazoles: potent \u03b1-glucosidase inhibitors. Sci Rep. 2023;13:8960. https:\/\/doi.org\/10.1038\/s41598-023-36046-y.","journal-title":"Sci Rep"},{"key":"3563_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-50711-2","volume":"14","author":"MK Ghomi","year":"2024","unstructured":"Ghomi MK, Dastyafteh N, Montazer MN, Noori M, Mojtabavi S, Faramarzi MA, et al. Synthesis, in vitro potency of inhibition, enzyme kinetics and in silico studies of quinoline-based \u03b1-glucosidase inhibitors. Sci Rep. 2024;14:501. https:\/\/doi.org\/10.1038\/s41598-023-50711-2.","journal-title":"Sci Rep"},{"key":"3563_CR51","doi-asserted-by":"publisher","first-page":"132058","DOI":"10.1016\/j.molstruc.2021.132058","volume":"1251","author":"H Ullah","year":"2022","unstructured":"Ullah H, Uddin I, Rahim F, Khan F, Sobia TM, Khan MU, et al. In vitro \u03b1-glucosidase and \u03b1-amylase inhibitory potential and molecular docking studies of benzohydrazide based imines and thiazolidine-4-one derivatives. J Mol Struct. 2022;1251:132058 https:\/\/doi.org\/10.1016\/j.molstruc.2021.132058.","journal-title":"J Mol Struct"},{"key":"3563_CR52","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1107\/S0021889808042726","volume":"42","author":"OV Dolomanov","year":"2009","unstructured":"Dolomanov OV, Bourhis LJ, Gildea RJ, Howard JAK, Puschmann H. OLEX2: a complete structure solution, refinement and analysis program. J Appl Crystallogr. 2009;42:339 https:\/\/doi.org\/10.1107\/S0021889808042726.","journal-title":"J Appl Crystallogr"},{"key":"3563_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S2053273314026370","volume":"71","author":"GM Sheldrick","year":"2015","unstructured":"Sheldrick GM. HELXT\u2013Integrated space-group and crystal-structure determination. Acta Crystallographica Section A. 2015;71:3 https:\/\/doi.org\/10.1107\/S2053273314026370.","journal-title":"Acta Crystallographica Section A"},{"key":"3563_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res. 2000;28:235 https:\/\/doi.org\/10.1093\/nar\/28.1.235.","journal-title":"Nucleic Acids Res"},{"key":"3563_CR55","unstructured":"Protein Data Bank. Available online: http:\/\/www.rcsb.org (accessed on 01 June 2025)."},{"key":"3563_CR56","unstructured":"BIOVIA DS software Dassault Syst\u00e8mes: San Diego CA USA, 2022."},{"key":"3563_CR57","unstructured":"CATALYST_4. 11 Software Users\u2019 Manual Accelrys Inc.: San Diego CA USA, 2005."},{"key":"3563_CR58","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1093-3263(02)00164-X","volume":"21","author":"CM Venkatachalam","year":"2003","unstructured":"Venkatachalam CM, Jiang X, Oldfield T, Waldman M. LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J Mol Graph Model. 2003;21:289 https:\/\/doi.org\/10.1016\/S1093-3263(02)00164-X.","journal-title":"J Mol Graph Model"},{"key":"3563_CR59","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1021\/ci100368t","volume":"51","author":"MO Taha","year":"2011","unstructured":"Taha MO, Habash M, Al-Hadidi Z, Al-Bakri A, Younis K, Sisan S. Docking-based Comparative intermolecular contacts analysis as new 3-D QSAR concept for validating docking studies and in silico screening: NMT and GP inhibitors as case studies. J Chem Inf Model. 2011;51:647 https:\/\/doi.org\/10.1021\/ci100368t.","journal-title":"J Chem Inf Model"},{"key":"3563_CR60","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1007\/s00894-012-1479-z","volume":"18","author":"MA Al-Sha\u2019er","year":"2012","unstructured":"Al-Sha\u2019er MA, Taha MO. Application of docking-based comparative intermolecular contacts analysis to validate Hsp90\u03b1 docking studies and subsequent in silico screening for inhibitors. \u200f. J Mol Model. 2012;18:4843 https:\/\/doi.org\/10.1007\/s00894-012-1479-z.","journal-title":"J Mol Model"},{"key":"3563_CR61","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11030-022-10434-4","volume":"27","author":"HA Basheer","year":"2023","unstructured":"Basheer HA, Taha MO. Discovery of new PKN2 inhibitory chemotypes via QSAR-guided selection of docking-based pharmacophores. Mol Divers. 2023;27:443 https:\/\/doi.org\/10.1007\/s11030-022-10434-4.","journal-title":"Mol Divers"},{"key":"3563_CR62","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00044-023-03057-3","volume":"32","author":"MA Al-Sha\u2019er","year":"2023","unstructured":"Al-Sha\u2019er MA, Taha MO, Alelaimat MA. Development of phosphoinositide 3-kinase delta (PI3K\u03b4) inhibitors as potential anticancer agents through the generation of ligand-based pharmacophores and biological screening. Med Chem Res. 2023;32:1109 https:\/\/doi.org\/10.1007\/s00044-023-03057-3.","journal-title":"Med Chem Res"},{"key":"3563_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3897\/pharmacia.71.e117192","volume":"71","author":"AH Abdullah","year":"2024","unstructured":"Abdullah AH, Alarareh AK, Al-Sha\u2019er MA, Habashneh AY, Awwadi FF, Bardaweel SK. Docking, synthesis, and anticancer assessment of novel quinoline-amidrazone hybrids. Pharmacia. 2024;71:1 https:\/\/doi.org\/10.3897\/pharmacia.71.e117192.","journal-title":"Pharmacia"},{"key":"3563_CR64","doi-asserted-by":"publisher","first-page":"e2604","DOI":"10.1002\/jmr.2604","volume":"30","author":"MA Al-Sha\u2019er","year":"2017","unstructured":"Al-Sha\u2019er MA, Almazari IS, Taha MO. Discovery of novel potent nuclear factor kappa-B inhibitors (IKK-\u03b2) via extensive ligand-based modeling and virtual screening. J Mol Recog. 2017;30:e2604 https:\/\/doi.org\/10.1002\/jmr.2604.","journal-title":"J Mol Recog"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03563-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03563-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03563-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:47:38Z","timestamp":1782380858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-026-03563-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3563"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03563-0","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}